Sudden Cardiac Death in Dilated Cardiomyopathy – Therapeutic OptionsPlötzlicher Herztod bei dilatativer Kardiomyopathie – therapeutische Optionen?

被引:12
|
作者
Wolfram Grimm
Bernhard Maisch
机构
[1] Department of Cardiology,
[2] Hospital of the Philipps University Marburg,undefined
[3] Germany,undefined
关键词
Key Words: Dilated cardiomyopathy; Arrhythmia risk stratification; Sudden death; Implantable cardioverter defibrillator; Schlüsselwörter: Dilatative Kardiomyopathie; Risikostratifikation für Arrhythmien; Plötzlicher Herztod; Implantierbarer Kardioverter-Defibrillator;
D O I
10.1007/s00059-002-2425-0
中图分类号
学科分类号
摘要
Despite routine use of angiotensin-converting enzyme (ACE) inhibitors, β-blockers and spironolactone in patients with heart failure due to dilated cardiomyopathy (DCM), these patients still have a considerable annual mortality rate of 5–10%. Sudden unexpected death accounts for up to 50% of all deaths and is most often due to rapid ventricular tachycardia or ventricular fibrillation and less often due to bradyarrhythmias or asystole.
引用
收藏
页码:750 / 759
页数:9
相关论文
共 25 条